#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome


In this study, we used deletions at 22q13, which represent a substantial source of human pathology (Phelan/McDermid syndrome), as a model for investigating the molecular mechanisms of terminal deletions that are currently poorly understood. We characterized at the molecular level the genomic rearrangement in 44 unrelated patients with 22q13 monosomy resulting from simple terminal deletions (72%), ring chromosomes (14%), and unbalanced translocations (7%). We also discovered interstitial deletions between 17–74 kb in 9% of the patients. Haploinsufficiency of the SHANK3 gene, confirmed in all rearrangements, is very likely the cause of the major neurological features associated with PMS. SHANK3 mutations can also result in language and/or social interaction disabilities. We determined the breakpoint junctions in 29 cases, providing a realistic snapshot of the variety of mechanisms driving non-recurrent deletion and repair at chromosome ends. De novo telomere synthesis and telomere capture are used to repair terminal deletions; non-homologous end-joining or microhomology-mediated break-induced replication is probably involved in ring 22 formation and translocations; non-homologous end-joining and fork stalling and template switching prevail in cases with interstitial 22q13.3. For the first time, we also demonstrated that distinct stabilizing events of the same terminal deletion can occur in different early embryonic cells, proving that terminal deletions can be repaired by multistep healing events and supporting the recent hypothesis that rare pathogenic germline rearrangements may have mitotic origin. Finally, the progressive clinical deterioration observed throughout the longitudinal medical history of three subjects over forty years supports the hypothesis of a role for SHANK3 haploinsufficiency in neurological deterioration, in addition to its involvement in the neurobehavioral phenotype of PMS.


Vyšlo v časopise: Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome. PLoS Genet 7(7): e32767. doi:10.1371/journal.pgen.1002173
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002173

Souhrn

In this study, we used deletions at 22q13, which represent a substantial source of human pathology (Phelan/McDermid syndrome), as a model for investigating the molecular mechanisms of terminal deletions that are currently poorly understood. We characterized at the molecular level the genomic rearrangement in 44 unrelated patients with 22q13 monosomy resulting from simple terminal deletions (72%), ring chromosomes (14%), and unbalanced translocations (7%). We also discovered interstitial deletions between 17–74 kb in 9% of the patients. Haploinsufficiency of the SHANK3 gene, confirmed in all rearrangements, is very likely the cause of the major neurological features associated with PMS. SHANK3 mutations can also result in language and/or social interaction disabilities. We determined the breakpoint junctions in 29 cases, providing a realistic snapshot of the variety of mechanisms driving non-recurrent deletion and repair at chromosome ends. De novo telomere synthesis and telomere capture are used to repair terminal deletions; non-homologous end-joining or microhomology-mediated break-induced replication is probably involved in ring 22 formation and translocations; non-homologous end-joining and fork stalling and template switching prevail in cases with interstitial 22q13.3. For the first time, we also demonstrated that distinct stabilizing events of the same terminal deletion can occur in different early embryonic cells, proving that terminal deletions can be repaired by multistep healing events and supporting the recent hypothesis that rare pathogenic germline rearrangements may have mitotic origin. Finally, the progressive clinical deterioration observed throughout the longitudinal medical history of three subjects over forty years supports the hypothesis of a role for SHANK3 haploinsufficiency in neurological deterioration, in addition to its involvement in the neurobehavioral phenotype of PMS.


Zdroje

1. BorgaonkarDS 1984 Chromosomal variation in man New York Liss

2. WilkieAOLambJHarrisPCFinneyRDHiggsDR 1990 A truncated human chromosome 16 associated with alpha thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n. Nature 346 868 871

3. LambJHarrisPCWilkieAOWoodWGDauwerseJG 1993 De novo truncation of chromosome 16p and healing with (TTAGGG)n in the alpha-thalassemia/mental retardation syndrome (ATR-16). Am J Hum Genet 52 668 676

4. FlintJCraddockCFVillegasABentleyDPWilliamsHJ 1994 Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet 3 505 512

5. NeumannAAReddelRR 2002 Telomere maintenance and cancer – look, no telomerase. Nat Rev Cancer 2 879 884

6. VarleyHPickettHAFoxonJLReddelRRRoyleNJ 2002 Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells. Nat Genet 30 301 305

7. MeltzerPSGuanXYTrentJM 1993 Telomere capture stabilizes chromosome breakage. Nat Genet 4 252 255

8. NingYLiangJCNagarajanLSchrockERiedT 1998 Characterization of 5q deletions by subtelomeric probes and spectral karyotyping. Cancer Genet Cytogenet 103 170 172

9. KnijnenburgJvan HaeringenAHanssonKBLankesterASmitMJ 2007 Ring chromosome formation as a novel escape mechanism in patients with inverted duplication and terminal deletion. Eur J Hum Genet 5 548 555

10. RossiERiegelMMessaJGimelliSMaraschioP 2008 Duplications in addition to terminal deletions are present in a proportion of ring chromosomes: Clues to the mechanisms of formation. J Med Genet 4 147 154

11. BallifBCWakuiKGajeckaMShafferLG 2004 Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements. Hum Genet 114 198 206

12. YatsenkoSABrundageEKRoneyEKCheungSWChinaultAC 2009 Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome. Hum Mol Genet 18 1924 1936

13. PhelanMCRogersRCSaulRAStapletonGASweetK 2001 22q13 deletion syndrome. Am J Med Genet 101 91 99

14. WilsonHLWongACShawSRTseWYStapletonGA 2003 Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 40 575 584

15. RodriguezLMartinez GuardiaNHerensCJamarMVerloesA 2003 Subtle trisomy 12q24.3 and subtle monosomy 22q13.3: Three new cases and review. Am J Med Genet A 122A 119 124

16. BonagliaMCGiordaRBeriSBigoniSSensiA 2009 Mosaic 22q13 deletions: Evidence for concurrent mosaic segmental isodisomy and gene conversion. Eur J Hum Genet 17 426 433

17. PhelanK 2007 22q13.3 deletion syndrome. GENEReviews, University of Washington, Seattle (www.genetests.org)

18. BonagliaMCGiordaRManiEAcetiGAnderlidBM 2006 Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 43 822 828

19. DurandCMBetancurCBoeckersTMBockmannJChasteP 2007 Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39 25 27

20. MoessnerRMarshallCRSutcliffeJSSkaugJPintoD 2007 Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 81 1289 1297

21. GauthierJSpiegelmanDPitonALafrenièreRGLaurentS 2009 Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet 150B 421 424

22. GauthierJChampagneNLafrenièreRGXiongLSpiegelmanD 2010 De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A 107 7863 7868

23. HamdanFFGauthierJArakiYLinDTYoshizawaY 2011 Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 88 306 316

24. GizaJUrbanskiMJPrestoriFBandyopadhyayBYamA 2010 Behavioral and cerebellar transmission deficits in mice lacking the autism-linked gene islet brain-2. J Neurosci 30 14805 14816

25. AnderlidBMSchoumansJAnnerenGTapia-PaezIDumanskiJ 2002 FISH-mapping of a 100-kb terminal 22q13 deletion. Hum Genet 5 439 443

26. PhamECrewsLUbhiKHansenLAdameA 2010 Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J 277 3051 3067

27. GongYLippaCFZhuJLinQRossoAL 2009 Disruption of glutamate receptors at shank-postsynaptic platform in alzheimer's disease. Brain Res 1292 191 198

28. LucianiJJde MasPDepetrisDMignon-RavixCBottaniA 2003 Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: Cytogenetic, molecular, and clinical analyses of 32 new observations. J Med Genet 40 690 696

29. JeffriesARCurranSElmslieFSharmaAWengerS 2005 Molecular and phenotypic characterization of ring chromosome 22. Am J Med Genet A 137 139 147

30. WongACNingYFlintJClarkKDumanskiJP 1997 Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am J Hum Genet 60 113 120

31. HeilstedtHABallifBCHowardLALewisRAStalS 2003 Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 72 1200 1212

32. MullerFWickyCSpicherAToblerH 1991 New telomere formation after developmentally regulated chromosomal breakage during the process of chromatin diminution in Ascaris lumbricoides. Cell 67 815 822

33. BottiusEBakhsisNScherfA 1998 Plasmodium falciparum telomerase: de novo telomere addition to telomeric and nontelomeric sequences and role in chromosome healing. Mol Cell Biol 18 919 925

34. HannesFVan HoudtJQuarrellOWPootMHochstenbachR 2010 Telomere healing following DNA polymerase arrest-induced breakages is likely the main mechanism generating chromosome 4p terminal deletions. Hum Mutat 31 1343 1351

35. KnightSJFlintJ 2000 Perfect endings: A review of subtelomeric probes and their use in clinical diagnosis. J Med Genet 37 401 409

36. ZhaoJBacollaAWangGVasquezKM 2010 Non-B DNA structure-induced genetic instability and evolution. Cell Mol Life Sci 67 43 62

37. ChristLACroweCAMicaleMAConroyJMSchwartzS 1999 Chromosome breakage hotspots and delineation of the critical region for the 9p-deletion syndrome. Am J Hum Genet 5 1387 1395

38. PhilippeABoddaertNVaivre-DouretLRobelLDanon-BoileauL 2008 Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood. Pediatrics 122 e376 82

39. DharSUdel GaudioDGermanJRPetersSUOuZ 2010 22q13.3 deletion syndrome: Clinical and molecular analysis using array CGH. Am J Med Genet A 152A 573 581

40. D'AntonioLBaggaP 2004 Computational methods for predicting intramolecular G-quadruplexes in nucleotide sequences. Proceedings of the 2004 IEEE Computational Systems Bioinformatics Conference (CSB 2004)

41. DelahayeAToutainAAbouraADupontCTabetAC 2009 Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3. Eur J Med Genet 52 328 332

42. WilsonHLCrollaJAWalkerDArtifoniLDallapiccolaB 2008 Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development. Eur J Hum Genet 16 1301 1310

43. SlackAThorntonPCMagnerDBRosenbergSMHastingsPJ 2006 On the mechanism of gene amplification induced under stress in Escherichia coli. PLoS Genet 2 e48 doi:10.1371/journal.pgen.0020048

44. HastingsPJIraGLupskiJR 2009 A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5 e1000327 doi:10.1371/journal.pgen.1000327

45. BoonePMBacinoCAShawCAEngPAHixsonPM 2010 Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat 31 1326 1342

46. VannesteEVoetTLe CaignecCAmpeMKoningsP 2009 Chromosome instability is common in human cleavage-stage embryos. Nat Med 15 577 583

47. ConlinLKThielBDBonnemannCGMedneLErnstLM 2010 Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum Mol Genet 19 1263 1275

48. LupskiJR 2010 New mutations and intellectual function. Nat Genet 42 1036 1038

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2011 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#